Evaxion A (EVAX) Change in Intangibles (2020 - 2021)

Evaxion A (EVAX) reported Change in Intangibles of -$60000.0 for Q3 2021, down 71.43% on a YoY basis from -$210000.0 in Q3 2020, and little changed quarter-over-quarter from -$60000.0 in Q2 2021.

Evaxion A (EVAX) Change in Intangibles (2020 - 2021) Analysis & Trends

Evaxion A has reported Change in Intangibles for 2 years, with the latest figure at -$60000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.96 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Regeneron Pharmaceuticals 63.59 Bn 54.83 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2021 -60,000.00
Sep 30, 2021 -60,000.00
Jun 30, 2021 -60,000.00
Jun 30, 2021 -60,000.00
Mar 31, 2021 -60,000.00
Mar 31, 2021 -60,000.00
Sep 30, 2020 -35,000.00
Sep 30, 2020 -35,000.00
Jun 30, 2020 -35,000.00
Jun 30, 2020 -35,000.00